Seven protective miRNA signatures for prognosis of cervical cancer

被引:22
|
作者
Liu, Bei [1 ]
Ding, Jin-feng [2 ]
Luo, Jian [3 ]
Lu, Li [4 ,5 ]
Yang, Fen [6 ]
Tan, Xiao-dong [1 ]
机构
[1] Wuhan Univ, Sch Publ Hlth, Wuhan 430071, Peoples R China
[2] Taizhou Hosp, Dept Anesthesiol, Taizhou 317000, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Geriatr Med, Wuhan 430030, Peoples R China
[4] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, Canc Epigenet Lab, Hong Kong 999077, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong 999077, Hong Kong, Peoples R China
[6] Hubei Univ Chinese Med, Dept Nursing, Wuhan 430063, Peoples R China
关键词
cervical cancer; survival analysis; Cox's model; GO enrichment; pathway analysis; TUMOR-GROWTH; COLON-CANCER; PROLIFERATION; INFORMATION; MIR-142-3P; EXPRESSION; BIOMARKER; SURVIVAL; INVASION; MIR-150;
D O I
10.18632/oncotarget.10678
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cervical cancer is the second cause of cancer death in females in their 20s and 30s, but there were limited studies about its prognosis. This study aims to identify miRNA related to prognosis and study their functions. TCGA data of patients with cervical cancer were used to build univariate Cox's model with single clinical parameter or miRNA expression level. Multivariate Cox's model was built using both clinical information and miRNA expression levels. At last, STRING was used to enrich gene ontology or pathway for validated targets of significant miRNAs, and visualize the interactions among them. Using univariate Cox's model with clinical parameters, we found that two clinical parameters, tobacco use and clinical stage, and seven miRNAs were highly correlated with the survival status. Only using the expression level of miRNA signatures, the model could separate patients into high-risk and low-risk groups successfully. An optimal feature-selected model was proposed based on two clinical parameters and seven miRNAs. Functional analysis of these seven miRNAs showed they were associated to various pathways related to cancer, including MAPK, VEGF and P53 pathways. These results helped the research of identifying targets for targeted therapy which could potentially allow tailoring of treatment for cervical cancer patients.
引用
收藏
页码:56690 / 56698
页数:9
相关论文
共 50 条
  • [31] Alteration of Gene and miRNA Expression in Cervical Intraepithelial Neoplasia and Cervical Cancer
    Dudea-Simon, Marina
    Mihu, Dan
    Pop, Laura Ancuta
    Ciortea, Razvan
    Malutan, Andrei Mihai
    Diculescu, Doru
    Ciocan, Cristina Alexandra
    Cojocneanu, Roxana Maria
    Simon, Vasile
    Bucuri, Carmen
    Mocan-Hognogi, Radu
    Braicu, Cornelia
    Berindan-Neagoe, Ioana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [32] Prognostic miRNA signatures
    不详
    CELL, 2008, 132 (05) : 719 - 719
  • [33] Circulating miRNA Signatures: Promising Prognostic Tools for Cancer Reply
    Hu, Zhibin
    Shen, Hongbing
    Zhang, Chenyu
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : E575 - E576
  • [34] Defining fallopian tube-derived miRNA cancer signatures
    Dejene, Selam B.
    Ohman, Anders W.
    Du, Wei
    Randhawa, Deepinder
    Bradley, Anand
    Yadav, Niraj
    Elias, Kevin M.
    Dinulescu, Daniela M.
    Setlur, Sunita R.
    CANCER MEDICINE, 2019, 8 (15): : 6709 - 6716
  • [36] Identification of specific miRNA signatures in EBC for non-invasive lung cancer diagnosis and prognosis: A proof-of-concept study
    Rai, Divyanjali
    Pattnaik, Bijay
    Bhatraju, Naveen
    Vadala, Rohit
    Tak, Jaya
    Kashyap, Seetu
    Verma, Umashankar
    Kumari, Jyoti
    Mittal, Saurabh
    Tiwari, Pawan
    Hadda, Vijay
    Madan, Karan
    Yadav, Geetika
    Dhaliwal, Rupinder Singh
    Guleria, Randeep
    Agrawal, Anurag
    Mohan, Anant
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [37] Recurrent cervical cancer: detection and prognosis
    Duyn, A
    Van Eijkeren, M
    Kenter, G
    Zwinderman, K
    Ansink, A
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (04) : 351 - 355
  • [38] PROGNOSIS AND REMOTE RESULTS IN CERVICAL CANCER
    Harutyunyan, L. S.
    NEW ARMENIAN MEDICAL JOURNAL, 2014, 8 (01): : 57 - 67
  • [39] Pembrolizumab improves Prognosis of Cervical Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (02) : 121 - 121
  • [40] Recurrent cervical cancer: detection and prognosis
    Duyn, A
    Van Eijkeren, M
    Kenter, G
    Zwinderman, K
    Ansink, A
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (08) : 759 - 763